FDA Investigator Christopher D Leach

Christopher D Leach has inspections in 7 countries as of 13 Nov 2023. Christopher D Leach has collaborated with a combinined 6132 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
162
Last Inspection Date:
13 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Canada, India, Spain, Denmark, Italy, Slovenia
Co-Investigator(s):
A Williams, Ademola O Daramola, Aditi S Thakur, Alan M Barker, Alan M Roberts, Alicia M Mozzachio, Amanda S Zorn, Amy Devlin, PhD, Ana E Morales, Ana L Kewes, Anastasia M Shields, Anders W Evenson, Andrew A Leboeuf, Andrew J Barrowcliff, Andrew Le, Anita Narula, PhD, Anthony F Lorenzo, Anthony J Ladner, Anthony R Ronga, Ariel Cruz Figueroa, Arsen Karapetyan, Ashley L Reiber, Audrey Dela Cruz, Azza Talaat, Barbara A Gullick, Blondell W Johnson, Bradley J Maunder, Brian D Nicholas, Brian D Nicholson, Brian P Emanuel, Brittani N Franklin, Brittany R Laymon, Bruce H Mccullough, Bryan L Mcguckin, Burnell M Henry, Carl A Huffman, III, Carl Lee, Carla J Lundi, Carlyn L Ray, Carrie Ann Plucinski, Caryn M Everly, Caryn M Mcnab, Cassandra L Abellard, CDR Sean T Creighton, Chad E Schmear, Chad J Whitwell, Chad W Rice, Charles D Brown, Charles L Zhou, Charles M Edwards, Charles R Cote, RIC, Charlie P Booker, Chase S Baldwin, Cheryl A Kmiec, Christina A Miller, Christopher B Harding, Clifton L Randell, Clotia Cabbey Mensah, Constantin Y Philopoulos, Cynthia M Goudeau, Daniel B Arrecis, Daniel J Brown, Daniel J Roberts, Dariusz Galezowski, Darrell E Luedtke, Daryl A Dewoskin, David A Oluwo, David J Gasparovich, David J Hafner, David M Beltran, David Perkins, Debra I Love, Debra L Boyd Seale, Dell S Moller, Demitria J Xiradakis, Denarvis C Mendenhall, Denise L Burosh, Denise M Digiulio, Dennis Cantellops Paite, Deyaa Shaheen, Diane L Raccasi, Dipesh K Shah, Don H Bark, PhD, Donna A Katz, Donna K Speer, Dr. Barbara D Paul, PhD, Dr. Gang Wang, PhD, Eboni S Funderburk, Edmund F Mrak, Jr, Elizabeth L Holmes, Elizabeth L Philpy, Emest F Bizjak, Emilie E Kahn, Enrico Joset Mangahis, Enrico Mangahis, Eric M Mueller, PharmD, Eric S Pittman, Eric S Rittman, Farhana Khan, Frank Wackes, Freed A Sharif, Geraldine D Sanders, Geraldine Sanders, Gregory R Dill, Harperd, Howard Sklamberg, Humera T Khan, Jacob G Luts, Jacob G Lutz, Jacqueline Mdiaz Albertini, James C Maclaughlin, James L Finn, James W Plucinski, Janae D Price, Jasjeet K Sekhon, Jason F Chancey, Javier O Vega, Jayne E Holcomb, Jeanne J Chiu, Jeanne M Morris, Jeffry A Bernhardt, Jennifer A D'angelo, Jennifer A Jones, Jennifer C Adams, Jennifer C Johnson, Jeremy W Rotton, Jerri E Lothrop, Jesse A Vazquez, Jessica L Burley, Joan A Loreng, Jocelyn C Turner, Joel D Hustedt, Jogy George, John M Seale, Jonathan G Swoboda, Jose Acruz Gonzalez, Jose E Melendez, DDC, Jose Martinez, Jr, Joseph A Morkunas, Joseph A Piechocki, Joseph D Cooper, Joseph R Lambert, Joshua M Adams, June P Page, Justin A Boyd, Karen E Masley, Karen Emasley Joseph, Katherine Szestypalow, Kathleen B Swat, Kathleen R Jones, PhD, Kathleen S Tormey, Kellia N Hicks, Kenneth H Williams, Kham Phommachanh, Kim Lthomas Cruse, Kimberly Lewandowski Walker, Kip J Hanks, Kristen E Szenderski, Kristin D Jarrell, Kshitij A Patkar, Kujtim Sadiku, Kyran R Gibson, La Tasha M Gunter, Lana K Waselewski, Latorie S Jones, Latoya A Griffith, Laura Fontan, MS, Laurel A Beer, Lauren A Crivellone, Laurie A Haxel, Laurimer Kuilan Torres, Lawrence J Stringer, LCDR Debra Emerson, LCDR Mark A Jimenez, RN, Leeterry Moore, Lequita M Mayhew, Leslie D Hintz, Liliya V Bubiy, Linda F Murphy, Linda S Mattingly, Linda Thai, Lindsey S Fleischman, Lisa C Lewis, Lisa Hayka, Lisa Hornback, Lisa T Michel, Logan M Ebeling, Lorelei S Jarrell, Lucas B Leake, Makini Cobourne Duval, PhD, Maksim A Levenchuk, Marcia A Worley, Margaret Torres Vazquez, Maria A Reed, Maria G Gutierrez Hoffman, Maria Gutierrez Hoffman, PhD, Marie Bbuen Bigornia, Marion Michaelis, Marisa E Stock, Mark E Frank, Mark G Peterson, Mark I Kaspar, Martin R Vowell, Marvin D Jones, Mary T Carden, Matthew R Maddox, Meisha R Sampson, Meisha Waters, Melanie W Pishnery, Melissa J Garcia, Melissa J Holz, Melkamu Getie Kebtie, PhD, Merry Christie, PhD, Michael D Robinson, Michael E Maselli, Michael Shanks, MS, Michael Y Philopoulos, Michele L Glendenning, Michele L Obert, Michele Perry Williams, Michelle J Glembin, Micmarie Ramos, Milva E Melendez, Milva Emelendez Perales, Min Chu Chen, Monica M Mcclure, Monika Borkowska, Mra Davism, Mra Munizn, Muna Algharibeh, Muralidhara B Gavini, PhD, Nancy J Lucas, Natasha R Johnson, Nibin Varghese, MS, Nicholas A Violand, Nicholas F Lyons, Nicholas J Presto, Nicholas L Paulin, Nicholas P Diorio, Nicholas Z Lu, Nicole J Clausen, Nicole S Williams, Noreen Muniz, Norman K Starks, Norman Wong, Omotunde O Osunsanmi, Pablo Alcantara, Paola S Barnett, Patrice S Hall, Patricia A Mcilroy, Patrick C Klotzbuecher, Paul L Bellamy, Paula A Trost, Paula P Demichael, Peng "Jeff" Zhou, Peng Zhou, Phung Thien Nguyen, Prabhu P Raju, Pradip N Akolkar, Rachel T Evans, Rafael Padilla, Ralph A Erickson, Ramesh Potla, PhD, Rebecca E Dombrowski, Rebecca Rodriguez, Renee L Anderson, Richard Jay Tucker, RS, Riley C Myers, PhD, Robert C Steyert, Robert D Tollefsen, Robert J Martin, Robert K Linn, Roberta W Cunningham, Rochelle K Kimmel, Rong Wang, PhD, Rose M Ashley, Rosemary A Sexton, Ross J Grigsby, Roy C Stephens, Russell K Riley, Ryan S Martin, Saleem A Akhtar, Samina S Khan, Sandra A Boyd, Sandra A Hughes, Santos E Camara, Sarah E Rhoades, Scott A Krause, Scott N Lim, Scott T Ballard, Seneca D Toms, Shafiq S Ahadi, Shana L Williams, Simone E Pitts, State Agency, Stefen D Mcmillan, Stephany J Wesley, Stephen C Mahoney, Stephen D Brown, Stephen D Eich, Steven Fong, MS, PhD, Sullan, Susan D Yuscius, Susan F Laska, MS, Susan M Jackson, Susan P Bruederle, Susan W Ciani, Susanna E Ford, Analyst, Susant Hadman, Tamara Brey, Tamara M Qtami, Tamil Arasu, PhD, Tara A Marshall, Tara C Alcazar, Tara R Gooen, That Q Dang, Thomas J Arista, Thunder N Dunkijacobs, Thuy T Nguyen, LCDR, Timothy Brennan, Timothy T Kapsala, Todd M Stankewicz, Todd Q Dang, Tonia F Bernard, Torrance J Slayton, Tracy Denison, PhD, Tricia S Martinez, Uruaku A Obasi, Vaishali J Patel, Vioela J Caze, Wayne E Seifert, Wendy G Tan, PhD, William D Sherman, William G Nelson, William J Leonard, William R Weissinger, Xiaokuang Lai, PhD, Xiomara Copeland, Yumi J Hiramine, Yvonne E Lozano, Yvonne Lozano, Zachary A Bogorad, Zerita White

Christopher D Leach's Documents

Publish Date Document Type Title
May, 2012 FDA 483 Fresenius Kabi USA, LLC - Form 483, 2012-05-04
November, 2013 EIR Cardinal Health, Inc. - EIR, 2013-11-14
November, 2012 EIR Fresenius Kabi USA, LLC - EIR, 2012-11-20
July, 2017 FDA 483 Amsino Healthcare (USA) Inc. - Form 483, 2017-07-10
April, 2016 EIR Eurofins CDMO Alphora Inc - EIR, 2016-04-29
August, 2011 EIR Cvs Caremark - EIR, 2011-08-23
December, 2013 FDA 483 Micro Measurement Laboratories, Inc. - Form 483, 2013-12-19
June, 2011 FDA 483 Abbott Molecular, Inc. - Form 483, 2011-06-01
September, 2016 FDA 483 Response Sage Products LLC - Form 483R, 2016-09-22
March, 2013 FDA 483 Home Intensive Care Pharmacy, Inc. - Form 483, 2013-03-01
November, 2009 FDA 483 Precision Dose Inc. - Form 483, 2009-11-24
January, 2018 FDA 483 Kashiv BioSciences, LLC - Form 483, 2018-01-26
June, 2011 EIR DMS Holdings, Inc. dba HealthSmart - EIR, 2011-06-07
September, 2016 EIR Option Care Enterprises dba Option Care - EIR, 2016-09-21
June, 2015 FDA 483 Response Baxter Healthcare Corporation - Form 483R, 2015-07-09
September, 2015 EIR Fresenius Kabi USA, LLC - EIR, 2015-09-01
February, 2014 FDA 483 Alva-Amco Pharmacal Companies, LLC - Form 483, 2014-02-11
September, 2015 FDA 483 Fresenius Kabi USA, LLC - Form 483, 2015-09-01
July, 2017 FDA 483 Response Amsino Healthcare (USA) Inc. - Form 483R, 2017-11-15
March, 2018 FDA 483 Medefil, Inc. - Form 483, 2018-03-29
June, 2015 FDA 483 Baxter Healthcare Corporation - Form 483, 2015-06-19
July, 2018 FDA 483 Woodstock Sterile Solutions, Inc - Form 483, 2018-07-03
September, 2016 FDA 483 Option Care Enterprises dba Option Care - Form 483, 2016-09-21
September, 2013 EIR ANDERSONBRECON INC. - EIR, 2013-09-20
January, 2013 EIR SA Analytical, LLC - EIR, 2013-01-16
November, 2014 FDA 483 Amsino Healthcare (USA) Inc. - Form 483, 2014-11-12
June, 2011 EIR Abbott Molecular, Inc. - EIR, 2011-05-24
September, 2016 FDA 483 Sage Products LLC - Form 483, 2016-09-01
August, 2014 FDA 483 Woodstock Sterile Solutions, Inc - Form 483, 2014-08-22
September, 2015 FDA 483 Response Fresenius Kabi USA, LLC - Form 483R, 2016-01-07
July, 2018 FDA 483 Agnitio Inc. - Form 483, 2018-07-19
March, 2012 EIR Mylan Institutional Inc. - EIR, 2012-03-13
July, 2017 EIR Amsino Healthcare (USA) Inc. - EIR, 2017-07-10
April, 2016 FDA 483 Response Eurofins CDMO Alphora Inc - Form 483R, 2016-05-19
March, 2013 FDA 483 American Red Cross National Headquarters - Form 483, 2013-03-01
August, 2018 FDA 483 Response Becton Dickinson Medical Systems - Form 483R, 2018-08-21
June, 2011 EIR Abbott Molecular, Inc. - EIR, 2011-06-01
September, 2009 FDA 483 General Organics Inc. - Form 483, 2009-09-04
May, 2018 FDA 483 Xellia Pharmaceuticals ApS - Form 483, 2018-05-08
January, 2016 FDA 483 Pharmedium Services, LLC - Form 483, 2016-01-04
March, 2013 FDA 483 Oakdell Pharmacy, Inc - Form 483, 2013-03-01
July, 2016 FDA 483 Xttrium Laboratories, Inc. - Form 483, 2016-07-11
October, 2017 FDA 483 The Gillette Company - Form 483, 2017-10-26
May, 2012 FDA 483 Rising Pharma Holdings, Inc. - Form 483, 2012-05-25
November, 2013 FDA 483 Cardinal Health, Inc. - Form 483, 2013-11-14
August, 2018 FDA 483 Becton Dickinson Medical Systems - Form 483, 2018-08-01
August, 2009 FDA 483 Stillman Co., Inc. - Form 483, 2009-08-18
September, 2016 EIR Sage Products LLC - EIR, 2016-09-01
May, 2012 EIR Rising Pharma Holdings, Inc. - EIR, 2012-05-25
June, 2011 FDA 483 Abbott Molecular, Inc. - Form 483, 2011-05-24
August, 2014 EIR Woodstock Sterile Solutions, Inc - EIR, 2014-08-22
May, 2017 FDA 483 Snyder Mark Drugs Roselle, Inc. d.b.a. Mark Drugs Pharmacy - Form 483, 2017-05-22
April, 2014 FDA 483 AFAM Concept, Inc. - Form 483, 2014-04-17
March, 2016 EIR Elorac Inc. - EIR, 2016-03-28
January, 2013 FDA 483 SA Analytical, LLC - Form 483, 2013-01-16
October, 2017 EIR Pfanstiehl Inc - EIR, 2017-10-05

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more